期刊文献+

低剂量紫杉醇对膀胱出口部分梗阻后膀胱形态变化的影响

Effect of low-dose paclitaxel on morphology of bladder in rats with infravesical obstruction
在线阅读 下载PDF
导出
摘要 目的:探讨低剂量紫杉醇对膀胱出口部分梗阻(BOO)大鼠膀胱形态变化的影响。方法:健康雌性Sprague-Dawley大鼠30只,随机分为空白对照组、BOO组和紫杉醇组。BOO组和紫杉醇组行尿道近端梗阻方式制备膀胱出口部分梗阻模型,空白对照组采用假手术方式处理。紫杉醇组于术后给予紫杉醇(溶于生理盐水)腹腔注射(0.3 mg/kg),每周2次。空白对照组与BOO组以等体积生理盐水同时间腹腔注射。4周后测量体重及膀胱重量,HE染色观察膀胱肌层增生情况;Masson三色染色观察并评价胶原纤维沉积;透射电镜观察逼尿肌超微结构改变。结果:与空白对照组相比,BOO组膀胱重量明显增加(0.376 g±0.052 g vs 0.112 g±0.014 g,P<0.05),膀胱逼尿肌明显增厚,胶原纤维面积占胶原与肌组织面积之和的比值下降(29.66%±2.69%vs 38.94%±3.67%,P<0.05),电镜下细胞中间连接明显减少,出现丰富的突触连接与桥粒连接,肌细胞间隙内有大量的胶原纤维。与BOO组相比,紫杉醇组膀胱重量显著降低(0.215 g±0.025 g vs 0.376 g±0.052 g,P<0.05),膀胱逼尿肌厚度减小,胶原纤维染色面积占胶原与肌组织面积之和的比值下降(19.94%±1.90%vs 29.66%±2.69%,P<0.05),细胞间连接以中间连接为主,细胞间隙内胶原纤维减少。结论:低剂量紫杉醇对BOO后膀胱形态结构的变化有一定的修复或逆转作用。 AIM: To investigate the effects of low-dose paclitaxel on the morphology of bladder after partial bladder outlet obstruction( BOO) in rats. METHODS: Healthy female Sprague-Dawley rats( n = 30) were randomly divided into sham operation group,BOO group and low-dose paclitaxel group. The rats in BOO group and low-dose paclitaxel group received operation to establish an obstruction model,while the rats in sham group underwent sham operation. After operation,the rats in low-dose paclitaxel group received intraperitoneal injection of paclitaxel at a dose of 0. 3 mg /kg twice a week for 4 weeks. At the same time,the animals in sham group and BOO group received the same volume of saline by intraperitoneal injection. Four weeks after operation,each rat was sedated and the bladder was weighted. Histological changes of the bladder were observed by HE staining. Collagen deposition in the bladder tissue was observed by Masson staining,and the fibrosis area was measured. The ultrastructure of the detrusor was studied by transmission electron microscopy. RESULTS: Compared with sham operation group,a significant increase in bladder weight( 0. 376 g ± 0. 052 g vs0. 112 g ± 0. 014 g,P 0. 05),the muscle hypertrophy,and a decrease in the percentage of collagen area [collagen /( collagen + muscle),29. 66% ± 2. 69% vs 38. 94% ± 3. 67%,P 0. 05]was observed in BOO group. Under electron microscope,intracellular connection had more gap junction and desmosomes than intermediate junction. The cell gap widened with a large amount of collagen fiber. Compared with BOO group,low-dose paclitaxel group decreased bladder weight( 0.215 g ±0.025 g vs 0.376 g ±0.052 g,P 〈0.05) and improved the muscle hypertrophy. The percentage of the collagen area was also decreased( 19. 94% ± 1. 90% vs 29. 66% ± 2. 69%,P〈 0. 05). The detrusor microstructure showed that the intermediate junction was characterized by a predominance among the intracellular connections,and the intercellular space contained less collagen fibers in low-dose paclitaxel group. CONCLUSION: Low-dose paclitaxel may ameliorate the morphological damage of the bladder and recover bladder function in the rats with BOO by slowing down the process of bladder fibrosis.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2014年第10期1896-1901,共6页 Chinese Journal of Pathophysiology
基金 徐州市科技发展基金资助项目(No.XF11C066)
关键词 膀胱出口梗阻 紫杉醇 透射电子显微镜 Bladder outlet obstruction Paclitaxel Transmission electron microscope
  • 相关文献

参考文献17

  • 1Kuo HC. Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy [ J ]. Urol Int, 2002, 68(2) :99-104.
  • 2Sakurai Y, Yoshida I, Tonomura S, et al. Weekly admin- istration of paclitaxel attenuated rectal stenosis caused by multiple peritoneal recurrence 8 years after the resection of gastric carcinoma [ J ]. Gastric Cancer, 2003, 6 (4) : 243- 249.
  • 3Zhang D, Sun L. Low-dose paelitaxel ameliorates renal fi- brosis in rat UUO model by inhibition of TGF-β/Smad ac- tivity[J]. Lab Invest, 2010, 90(3) : 436-447.
  • 4Sarma AV, Wei Jr. Benign prostatic hyperplasia and lower urinary tract symptoms[J]. N Engl J Med, 2012, 367(3) :248-257.
  • 5Roehrborn C. Benign prostatic hyperplasia and lower uri- nary tract symptom guidelines [ J ]. Can Urol Assoc J, 2012, 6(5 Suppl 2):S130-S132.
  • 6Metcalfe PD, Wang J, Jiao H, et al. Bladder outlet ob- struction: progression from inflammation to fibrosis [ J ].BJU Int, 2010, 106(11) :1686-1694.
  • 7Kitajima K, Aoba T, Pringle KC, et al. Bladder develop- ment following bladder outlet obstruction in fetal lambs: optimal timing of fetal therapy[J]. J Pediatr Surg, 2010, 45 ( 12 ) : 2423-2430.
  • 8Ku JH, Kim Y, Moon KC, et al. In vivo hepatoeyte growth faetor gene transfer to bladder smooth musele after bladder outlet obstruction in the rat: a morphometric anal- ysis[J]. J Urol, 2006, 176(3) :1230-1235.
  • 9周逢海,宋波,金锡御,范立新.逼尿肌不稳定缝隙连接介导细胞间通讯的研究[J].中华泌尿外科杂志,2004,25(4):260-262. 被引量:17
  • 10杨进益,叶林,侯旭,姜兴金,吴永安.前列腺增生症患者膀胱逼尿肌超微结构的研究[J].临床泌尿外科杂志,2004,19(1):34-35. 被引量:4

二级参考文献26

  • 1[1]Hindley R G, Brierly R D, Mclarty E, et al. A qualitative ultrastructural study of the hypocontractile detrusor. J Urol, 2002, 168:126-131.
  • 2[2]Elbadawi A. Pathology and pathophysiology of detrusor in incontinence. Urol Clin North Am,1995,22:499-512.
  • 3[3]Charlton R G, Morley A R, Chambers P, et al. Focal changes in nerve, muscle and connective tissue in normal and unstable human bladder. BJU Int,1999,84:953-960.
  • 4[4]Elbadawi A, Yalla S V, Resnick N M. Structural basis of geriatric voiding dysfunction. Ⅱ. Aging detrusor: normal versus impaired contractility. J Urol, 1993,150:1656-1657.
  • 5Kennedy AS, Sonett JR, Orens JB, et al. High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations. J Heart Lung Transplant, 2000, 19 : 155-159.
  • 6Spector JE, Werkhaven JA, Spector NC, et al. Preservation of function and histologic appearance in the injured glottis with topical mitomycin-C. Laryngoscope, 1999, 109 : 1125-1129.
  • 7Rahbar R, Shapshay SM, Healy GB. Mitomycin : effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol, 2001, 110:1-6.
  • 8Cortes de Miguel S, Cabeza Barrera J, Gallardo Medina M, et al. Topical endotracheal mitomycin C as a complementary treatment for endoscopic treatment of recurrent laryngotracheal stenosis. Farm Hosp, 2011, 35:23-25.
  • 9Roh JL, Lee YW, Park CI. Can mitomycin C really prevent airway stenosis? Laryngoscope, 2006, 116:440-445.
  • 10Roh JL, Kim DH, Rha KS, et al. Benefits and risks of mitomycin use in the traumatized tracheal mucosa. Otolaryngol Head Neck Surg, 2007, 136:459-463.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部